Javascript must be enabled to continue!
Age, gender, and ethnicity are associated with higher all-cause mortality in hospitalized patients with heparin-induced thrombocytopenia: A nationwide analysis
View through CrossRef
Abstract
Introduction
Heparin-induced thrombocytopenia (HIT) is a life-threatening immunologic reaction to heparin exposure that is associated with substantial morbidity and mortality. Limited research is available on host-dependent risk factors, such as age, gender, and ethnicity. This study aims to characterize any association between age, gender, ethnicity, and mortality in HIT patients to better identify patient populations at increased risk.
Methods
This is a retrospective case control analysis of all-cause mortality in 72,935 patients with a diagnosis of HIT between 2016–2020. Adult patients with HIT were selected using the ICD-10 code D75.82 (HIT) for inclusion and evaluated by demographic, clinical, and hospital characteristics. Odds ratios were calculated for continuous variables using 95% confidence intervals. Multivariable logistic regression was used to ascertain the odds of binary clinical outcomes relative to patient and hospital characteristics as well as the odds of clinical outcomes over time.
Results
Our analysis indicates that hospitalized patients with HIT are at 5 times higher odds of mortality than in those without HIT (OR: 5.42, 95% CI: 5.15–5.71, p < 0.001). Our data also indicates significantly higher odds of HIT-associated mortality based on patient age, gender, and ethnicity. By age, HIT patients at the highest risk of mortality were found to be between ages 46–60 (Odds Ratio (OR): 2.60, 95% CI: 1.58–4.25), p < 0.001). By gender, females with HIT are at significantly lower odds of mortality compared to males (OR: 0.90, 95% CI: 0.82–0.99, p < 0.001). By ethnicity, Hispanic patients are at the highest risk of mortality (OR: 1.52, 95% CI: 1.31–1.77, p < 0.001), followed by black patients (OR: 1.45, 95% CI: 1.27–1.66, p < 0.001), and then Asian patients (OR: 1.31, 95% CI: 1.00-1.72, p = 0.05).
Conclusion
HIT remains a clinical diagnosis based on quantitative criteria such as thrombocytopenia relative to baseline and timing of platelet decline but does not take into consideration other clinical variables that may stratify patients by increased risk. This study elucidates the relationship between host-dependent risk factors such as age, gender, and ethnicity, on the risk of all-cause mortality associated with HIT.
Springer Science and Business Media LLC
Title: Age, gender, and ethnicity are associated with higher all-cause mortality in hospitalized patients with heparin-induced thrombocytopenia: A nationwide analysis
Description:
Abstract
Introduction
Heparin-induced thrombocytopenia (HIT) is a life-threatening immunologic reaction to heparin exposure that is associated with substantial morbidity and mortality.
Limited research is available on host-dependent risk factors, such as age, gender, and ethnicity.
This study aims to characterize any association between age, gender, ethnicity, and mortality in HIT patients to better identify patient populations at increased risk.
Methods
This is a retrospective case control analysis of all-cause mortality in 72,935 patients with a diagnosis of HIT between 2016–2020.
Adult patients with HIT were selected using the ICD-10 code D75.
82 (HIT) for inclusion and evaluated by demographic, clinical, and hospital characteristics.
Odds ratios were calculated for continuous variables using 95% confidence intervals.
Multivariable logistic regression was used to ascertain the odds of binary clinical outcomes relative to patient and hospital characteristics as well as the odds of clinical outcomes over time.
Results
Our analysis indicates that hospitalized patients with HIT are at 5 times higher odds of mortality than in those without HIT (OR: 5.
42, 95% CI: 5.
15–5.
71, p < 0.
001).
Our data also indicates significantly higher odds of HIT-associated mortality based on patient age, gender, and ethnicity.
By age, HIT patients at the highest risk of mortality were found to be between ages 46–60 (Odds Ratio (OR): 2.
60, 95% CI: 1.
58–4.
25), p < 0.
001).
By gender, females with HIT are at significantly lower odds of mortality compared to males (OR: 0.
90, 95% CI: 0.
82–0.
99, p < 0.
001).
By ethnicity, Hispanic patients are at the highest risk of mortality (OR: 1.
52, 95% CI: 1.
31–1.
77, p < 0.
001), followed by black patients (OR: 1.
45, 95% CI: 1.
27–1.
66, p < 0.
001), and then Asian patients (OR: 1.
31, 95% CI: 1.
00-1.
72, p = 0.
05).
Conclusion
HIT remains a clinical diagnosis based on quantitative criteria such as thrombocytopenia relative to baseline and timing of platelet decline but does not take into consideration other clinical variables that may stratify patients by increased risk.
This study elucidates the relationship between host-dependent risk factors such as age, gender, and ethnicity, on the risk of all-cause mortality associated with HIT.
Related Results
Impact of Common Anticoagulants on Complete Blood Count Parameters Among Humans
Impact of Common Anticoagulants on Complete Blood Count Parameters Among Humans
Abstract
Introduction
Among the most frequently used anticoagulants in hematological testing are tetra-acetic acid (EDTA), sodium citrate, and sodium heparin. However, there is a n...
Case Report: Maggots' Infestation As a Predisposing Condition for Heparin-Induced Thrombocytopenia, a Newest Entity
Case Report: Maggots' Infestation As a Predisposing Condition for Heparin-Induced Thrombocytopenia, a Newest Entity
Abstract
Introduction
Thromobocytopenia is a well-recognized complication of heparin with risk of venous or arterial thrombosis. Heparin induced throm...
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Abstract
Introduction
Given pregnancy's significant impact on hematological parameters, monitoring these changes across trimesters is crucial. This study aims to evaluate hematolog...
Clinical and economic burden of heparin-induced thrombocytopenia in hospitalized patients undergoing percutaneous peripheral arterial interventions
Clinical and economic burden of heparin-induced thrombocytopenia in hospitalized patients undergoing percutaneous peripheral arterial interventions
Background
Percutaneous peripheral arterial intervention (PPAI) patients are at a high risk of developing heparin-induced thrombocytopenia due to the need for r...
Novel ELISA-Based Assay for Detection of Complement Activation By PF4/Heparin Complexes
Novel ELISA-Based Assay for Detection of Complement Activation By PF4/Heparin Complexes
Abstract
The immune response to platelet factor 4 (PF4)/heparin complexes is a frequent iatrogenic complication of heparin therapy associated with development of hep...
HEPARIN BINDING TO HUMAN MONOCYTES: MODULATION BY HISTIDINE-RICH GLYCOPROTEIN
HEPARIN BINDING TO HUMAN MONOCYTES: MODULATION BY HISTIDINE-RICH GLYCOPROTEIN
Heparin and its related glycosaminoglycans interact with a variety of cell types and, irrespective of their anticoagulant activities, have a complex and biologically important infl...
Thrombocytopenia in post Covid era: puzzle in the diagnosis.
Thrombocytopenia in post Covid era: puzzle in the diagnosis.
World Health Organization declared the outbreak of coronavirus disease 2019 (COVID-19) a pandemic on March 11, 2020, researchers and clinicians have worked diligently to learn ever...
HEPARIN STIMULATES FIBROBLAST GROWTH INDUCED BY PDGF
HEPARIN STIMULATES FIBROBLAST GROWTH INDUCED BY PDGF
Heparin binds to smooth muscle cells and endothelial cells. It inhibits the proliferation of the smooth muscle cells and modulates the growth of endothelial cells. Fibroblasts whic...

